ENGN Q2 2025 Earnings — enGene Holdings Inc. Revenue & Financial Results | Market Cap Arena

ENGNenGene Holdings Inc.

$359M

Q2 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$106,000

Operating Income

$27M

Net Income

$26M

EPS (Diluted)

$0.51

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$23M

Free Cash Flow

-$23M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$267M

Total Liabilities

$39M

Stockholders' Equity

$227M

Cash & Equivalents

$58M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$106,000	-$78,000	-35.9%
Operating Income	$27M	-$17M	+256.7%
Net Income	$26M	-$15M	+272.3%